Article Information
History
- January 26, 2021.
Article Versions
- You are currently viewing Version 1 of this article (January 26, 2021 - 05:48).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Camille Lassale, PhDa,b,c,*,
- Mark Hamer, PhDd,
- Álvaro Hernáez, PharmD, PhDa,b,e,
- Catharine R. Gale, PhDf,g and
- G. David Batty, PhD, DScc
- aHospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
- bCIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
- cDepartment of Epidemiology and Public Health, University College London, UK
- dDivision of Surgery and Interventional Sciences, Faculty Medical Sciences, University College London, London, UK
- eAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
- fMRC Lifecourse Epidemiology Unit, University of Southampton, UK
- gLothian Birth Cohorts, Department of Psychology, University of Edinburgh, UK
- ↵*Correspondence: Camille Lassale, PhD, Hospital del Mar Medical Research Institute, Carrer Doctor Aiguader 88, 08003, Barcelona, Spain. Telephone: +34 933 16 17 19 Email: classale{at}imim.es
Conflict of interest: The authors declare no conflict of interest.
Author contributions: GDB, MH and CL generated the idea for the present analyses; CRG prepared the data set; CL analysed the data; and CL prepared a draft of the manuscript on which all authors commented.
Posted January 26, 2021.
High density lipoprotein cholesterol and risk of subsequent COVID-19 hospitalisation: the UK Biobank study
